Hi dear colleagues, I recently took the CRCP exam but unfortunately did not pass. I used the recommended study materials, yet I was unable to succeed this time. I would greatly appreciate any guidance, tips, or strategies you might have for preparing ...

Hi Edgar, Thank you for sharing these thoughtful insights and practical examples from your experience in rare and orphan disease trials. Your point about involving patient advocacy groups early in protocol design is especially interesting, particularly ...

Hi Rachana, Thank you for sharing these insights. The point about shifting from vendor "management" to true partnership is especially valuable in rare disease trials, where operational success often depends on close alignment across multiple stakeholders. ...